12:00 AM
May 21, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

OraQuick In-Home HIV test regulatory update

FDA's Blood Products Advisory Committee voted 17-0 that data show OraSure's OTC OraQuick In-Home HIV Test is safe and effective. The panel also unanimously voted that the benefits of the...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >